Story at-a-glance 

As efficacy trials are getting underway, vaccine makers demand indemnity against lawsuits that may arise from the use of a fast-tracked Ebola vaccine

There may not be enough Ebola victims to justify pandemic classification in the US; so far, Continue reading →